IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma

The aim of this editorial is to focus on the urgent need to improve clinical outcomes in patients with bulky primary anal canal carcinoma.

Detalles Bibliográficos
Autores principales: De Felice, Francesca, Franco, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Perspectives in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645633/
https://www.ncbi.nlm.nih.gov/pubmed/37962690
http://dx.doi.org/10.1007/s12032-023-02224-1
_version_ 1785147394713714688
author De Felice, Francesca
Franco, Pierfrancesco
author_facet De Felice, Francesca
Franco, Pierfrancesco
author_sort De Felice, Francesca
collection PubMed
description The aim of this editorial is to focus on the urgent need to improve clinical outcomes in patients with bulky primary anal canal carcinoma.
format Online
Article
Text
id pubmed-10645633
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-106456332023-11-14 IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma De Felice, Francesca Franco, Pierfrancesco Med Oncol Perspectives in Oncology The aim of this editorial is to focus on the urgent need to improve clinical outcomes in patients with bulky primary anal canal carcinoma. Springer US 2023-11-14 2023 /pmc/articles/PMC10645633/ /pubmed/37962690 http://dx.doi.org/10.1007/s12032-023-02224-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Perspectives in Oncology
De Felice, Francesca
Franco, Pierfrancesco
IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
title IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
title_full IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
title_fullStr IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
title_full_unstemmed IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
title_short IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
title_sort iap inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
topic Perspectives in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645633/
https://www.ncbi.nlm.nih.gov/pubmed/37962690
http://dx.doi.org/10.1007/s12032-023-02224-1
work_keys_str_mv AT defelicefrancesca iapinhibitorpluschemoradiotherapyforthetreatmentofbulkyanalcanalcarcinoma
AT francopierfrancesco iapinhibitorpluschemoradiotherapyforthetreatmentofbulkyanalcanalcarcinoma

Ejemplares similares